SOT 55th Annual Meeting Recap

Several members of the Klaunig Lab attended the Society of Toxicology’s 55th Annual Meeting and ToxExpo, which was held from March 13-17th, 2016 in New Orleans, Louisiana. The SOT meeting always promises stimulating talks, presentations on breakthroughs in the field of toxicology and educational and professional networking opportunities. The meeting was held at the Ernest N. Morial Convention Center in New Orleans, which was a terrific venue along the banks of the Mississippi River. In addition to attending the meeting, several students and faculty members participated in poster sessions and presentations.

Dr. James Klaunig gave a presentation titled, “Role of Endogenous Oxidative Stress in Understanding and Assessing MOA of Exogenous Exposure to Toxic Agents” during the workshop session, Bringing More Science into the Process of Risk Assessment for Endogenous Chemicals with Exogenous Exposures.

Dr. Zemin Wang presented a talk, “Mode of Action of Triclosan Induced Mouse Liver Tumors” during the platform session, Investigating Mode of Action in Chemical Carcinogenesis.

Yibin Liu presented a poster titled, “The Effect of Green Tea Extract on Working Memory in Healthy Women” during the Natural Products poster session.

Shawn SOT 2016

Shawn Li with his poster at the SOT meeting.

Shawn Li presented a poster titled, “Mode of Action of PFOA Induced Liver and Pancreatic Acinar Cell Tumors in Rats” during the Carcinogenesis II poster session.

 

 

 

 

Ben SOT 2016

Ben Elser with his poster at the SOT meeting.

 

Ben Elser, who won the 2016 Pfizer SOT Undergraduate Student Travel Award, presented a poster titled, “Mechanism of 1,3-Dichloropropene Induced Liver Tumors in Rat” during the Carcinogenesis II poster session, as well.

 

 

 

 

 

Additionally, Dr. Klaunig was a collaborator on two external posters, the first by Dr. Brian Hughes titled, “Evaluation of Chemically-Induced Choline Deficiency as the Mode of Action for Diethanolamine-Induced Mouse Liver Tumors” and the second by Dr. Aparajita Chowdhury titled, “The Effects of Polyhexamethylene Biguanide (PHMB) on Rat Liver”.
Overall, the SOT 55th Annual Meeting in New Orleans, Louisiana was a productive and enlightening experience for all in attendance. Members of the Klaunig Lab were enthusiastic about the connections that were made and the possibilities for future collaboration. We look forward to attending the next SOT 56th Annual Meeting in Baltimore, Maryland in 2017.

 

More information on the SOT Annual Meeting can be found on the SOT website.

 

2015 ARASP Endogenous Exposures Webinar Series

The Center for Advancing Risk Assessment Science and Policy (ARASP) created a four part webinar series focusing on endogenous exposures and Dr. Klaunig was invited to be a key speaker. Dr. William Farland of Colorado State University acted as the Lead Facilitator, while Dr. Klaunig of Indiana University and Dr. James Swenberg of the University of North Carolina were the speakers. Webinar I focused on ‘Framing the Issue’ and took place on April 29th, 2015 from 2:00 – 4:00 pm. The webinar series was created to explore technical and policy considerations when conducting risk assessments on chemicals with endogenous and exogenous exposures.

More information on ARASP and the webinar series can be found on the ARASP website.

Dr. Klaunig on list of Thomson Reuters’ Highly Cited Researchers 2014

Dr. James Klaunig has been named one of the top scholars in science by Thomson Reuters as he made the newly generated list of “Highly Cited Researchers 2014”. This distinction can be earned by publishing the highest quality research that ranks in the top 1% “most cited for their subject field and year of publication– between 2002 and 2012” (Sciencewatch). Highly Cited Researchers lists more than 3,000 authors in 21 science and social science disciplines.

Dr. Klaunig is one of only three researchers at Indiana University to make this list. Other researchers at Indiana University to make the list include, Dr. Ken Mackie of the Department of Psychological and Brain Sciences and Dr. A. Keith Dunker of the Department of Biochemistry and Molecular Biology. This is a very exciting achievement for both, Dr. Klaunig and the Klaunig lab. Congratulations on this distinguished recognition Dr. Klaunig!

More information on the “Highly Cited Researchers 2014” list can be found on the Highly Cited webpage and Worlds Most Influential Scientific Minds 2014.

Dr. James E. Klaunig Appointed to Editor-in-Chief of HESI Publications

Dr. James E. Klaunig has been appointed to Editor-in-Chief of the HESI Publications Peer Review Process by the HESI Board of Trustees for the period June 2014 to June 2017. Dr. Klaunig was selected from a group of highly qualified candidates with international recognition, familiarity with HESI and prior editorial experience for selective peer-reviewed scientific journals. Dr. Klaunig, as the Editor-in-Chief, is charged with the task of safeguarding the science of manuscripts developed by HESI for publication. Megan Agnew serves as the Editorial Assistant of HESI Publications.

More information about HESI and the peer review process can be found on the HESI website.

SOT Update – Dr. Klaunig Elected to the Presidential Track of the Carcinogenesis Specialty Section

In March 2013, at the recent Society of Toxicology meeting, Dr. James Klaunig was elected to the presidential track of the Carcinogenesis Speciality Section of the Society of Toxicology. Dr. Klaunig will initially serve as Vice-President elect for two consecutive years 2013 and 2014, followed by President of the Specialty Section in 2015 and Past-President in 2016.

The Carcinogenesis Specialty Section is one of the oldest specialty sections of the SOT and serves as an information resource for SOT scientists around the world with interest in current and topical carcinogenesis research. It also provides for the exchange of educational materials and resources to the broader scientific community, advising and updating regulatory agencies, the media, and the public worldwide on the latest and most relevant information on carcinogenesis.  In addition, it serves to recognize current and developing leaders in carcinogenesis research through awards and sponsored presentations. The membership is multidisciplinary and drawn from academia, industry, and government in areas of expertise including biotechnology, environmental health, and pharmaceutical and food safety.  The members have a broad range of interests that include, but are not limited to, the understanding of genetic susceptibility to disease phenotypes at the molecular, cellular, whole organism, and population level as well as to understanding the molecular mechanisms that underlie functional changes due to toxicology and carcinogenesis.

More information about the SOT Carcinogenesis Specialty Section can be found on the Specialty Section’s website: Carcinogenesis Specialty Section

Dr. Klaunig’s session at the 39th Annual Summer Meeting of The TOX Forum

On July 8th, 2013, Dr. James Klaunig organized and chaired a session at the 39th Annual Summer Meeting of The Toxicology Forum in Aspen, Colorado. The session, entitled “Adverse Versus Adaptive Effects in Toxicology; Implications for Human Risk” explored the definitions and applications of adverse and adaptive toxicological responses in toxicology studies and their application to human health and human risk assessment. He presented an overview of the topic for discussion, which was followed by research reports by Dr. Bill Farland (Colorado State University), Dr. Jay Goodman (Michigan State University), and Dr. James Swenberg (University of North Carolina). In addition to the session, Dr. Klaunig serves as a member of the Board of Directors for The Toxicology Forum.

The Toxicology Forum is an international, nonprofit organization that is devoted to conducting open dialogues among various segments of society concerned with problems in toxicology. At our meetings, views are exchanged among experts from domestic and international government regulatory and health agencies, industry, academia, ‘political policymakers’, and public interest groups. The Toxicology Forum aims to provide a scrupulously balanced approach to the topics and issues presented at The Forum with alternative positions presented for each issue.

More information can be found on The Toxicology Forum’s website: The Toxicology Forum

 

National Institutes of Health Grant Review Panel

On June 20, 2013, Dr. James Klaunig chaired a grant review panel for the National Cancer Institute of the National Institutes of Health (NIH).  The panel reviewed a proposal, which addressed the “development of clinical automated multiplex affinity capture technology for detecting low abundance cancer related proteins and peptides”.  These proposals were in response to a Small Business Innovation Research (SBIR) Program’s Request For Proposals (RFP).

More information on the National Cancer Institute’s SBIR program can be found on the NCI website.

Study Warns of Toxic Flame Retardants in Most Couches

“More than one-third of all couches in the United States are thought to contain potential toxins that can be dangerous for humans to inhale as furniture foam disintegrates into dust, according to a Duke University and University of  California-Berkeley study.” – ABC News, Ashley Jennings

Read more at the abc News website: http://abcnews.go.com/blogs/health/2012/11/28/study-warns-of-toxic-flame-retardants-in-most-couches/